Processing

Please wait...

Settings

Settings

Goto Application

1. CA2267207 - METHODS FOR DETECTING OR ASSAYING VIRUS

Office Canada
Application Number 2267207
Application Date 04.08.1998
Publication Number 2267207
Publication Date 11.02.1999
Grant Number
Grant Date 28.10.2008
Publication Kind C
IPC
C12N 7/06
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
7Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
04Inactivation or attenuation; Producing viral sub-units
06by chemical treatment
G01N 33/569
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
G01N 33/576
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
576for hepatitis
CPC
G01N 33/5767
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
576for hepatitis
5767non-A, non-B hepatitis
G01N 33/56983
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
569for microorganisms, e.g. protozoa, bacteria, viruses
56983Viruses
G01N 2333/02
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2333Assays involving biological materials from specific organisms or of a specific nature
005from viruses
01DNA viruses
02Hepadnaviridae, e.g. hepatitis B virus
G01N 2333/18
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
2333Assays involving biological materials from specific organisms or of a specific nature
005from viruses
08RNA viruses
18Togaviridae; Flaviviridae
Applicants TONEN CORPORATION
Inventors AOYAGI, KATSUMI
OHUE, CHIHARU
IIDA, KUMIKO
KIMURA, TATSUJI
YAGI, SHINTARO
Priority Data 10/218136 31.07.1998 JP
9/209515 04.08.1997 JP
9/209522 04.08.1997 JP
Title
(EN) METHODS FOR DETECTING OR ASSAYING VIRUS
(FR) METHODES PERMETTANT DE DETECTER OU D'ANALYSER UN VIRUS
Abstract
(EN)
A method for treating a virus-containing sample characterized by treating the sample with a treating solution containing (1) an anionic surfactant and (2) any of an amphoteric surfactant, a nonionic surfactant and a protein denaturing agent; a method for assaying a virus by using this treating method; a method for treating a virus-containing sample characterized by treating the sample with a treating solution containing (1) a chaotropic ion and (2) an acidifying agent; a method for assaying a virus by using this treating method; a method for assaying a virus characterized by assaying a virus antigen and a virus antibody in the presence of a surfactant which has alkyl having or more carbon atoms and a secondary, tertiary or quaternary amine and/or a nonionic surfactant on the basis of the bonds to the probes thereof; and a monoclonal antibody for effecting this method and a hybridoma producing the same.